M. Adenot

6 A Practical Approach to Computational Models of the Blood-Brain Barrier

M. Adenot, 2007 .

Applications of a Blood-Brain Barrier Technology Platform to Predict CNS Penetration of Various Chemotherapeutic Agents. 2. Cationic Peptide Vectors for Brain Delivery

J. Scherrmann, N. Perrière, M. Adenot, 2007, Chemotherapy.

Peptide dynamic fingerprints: a tool for investigating the role of conformational flexibility for GLP‐1 analogs affinity

C. Sarrauste de Menthière, G. Grassy, M. Adenot, 2005, Journal of peptide science : an official publication of the European Peptide Society.

Interest of cluster significance analysis in structure-affinity relationships for non-xanthine heterocyclic antagonists of adenosine

G. Grassy, M. Adenot, P. Bonnet, 1997 .

Peptides quantitative structure-function relationships: an automated mutation strategy to design peptides and pseudopeptides from substitution matrices.

C. Sarrauste de Menthière, G. Grassy, M. Adenot, 1999, Journal of molecular graphics & modelling.

Structure-activity relationships of steroids with mineralocorticoid activity

G. Grassy, J. Fagart, M. Rafestin-Oblin, 1997 .

Clinical Presentation of Severe Viral Encephalitis With Known Causative Agents in Children

E. Javouhey, D. Floret, M. Adenot, 2014, Journal of child neurology.

Blood-Brain Barrier Permeation Models: Discriminating between Potential CNS and Non-CNS Drugs Including P-Glycoprotein Substrates

Marc Adenot, Roger Lahana, M. Adenot, 2004, J. Chem. Inf. Model..